More than 80% of all chemotherapy patients are incorrectly dosed.
This is because two patients with the same body surface area (derived from a patient’s height and weight) are given the same chemotherapy dose, even though they may have completely different body compositions. Different body compositions lead to different degrees of chemotherapy overdosing, resulting in toxicities.
One third of chemotherapy patients therefore stop treatment early due to overdosing leading to severe toxicities.
Incorrect chemotherapy dosing leads to significantly poorer cancer treatment outcomes.
Our patented platform interprets CT imaging and clinical data to predict optimal dosing, reducing toxicity improving survival rates.
Provides a comprehensive 3D body composition analysis combined with chemotherapy dosing accuracy.
Currently we are 3 times more accurate in predicting correct dosing compared to current methods for colorectal cancer.
Full seamless integration into health electronic medical records. Providing additional information on global patient health status including bone and muscle health.
Clinician centred App providing tailored chemotherapy dosing.
Addressing critical oncology dosing challenges.
Sub-Text
Utilizes advanced AI to analyze CT scans, providing a 3D view of patient body composition for precise dosing.
Recommends chemotherapy doses tailored to each patient's unique physiology, enhancing treatment safety and efficacy.
Designed to integrate smoothly into existing hospital workflows, ensuring ease of use without added complexity.
Our patented image-based AI engine is a world-first in chemotherapy dose optimization, offering a unique competitive edge.
